Back to top

Quidel Corporation (QDEL)

(Delayed Data from NSDQ)

$119.51 USD


-2.81 (-2.30%)

Updated Apr 20, 2021 04:00 PM ET

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy25.41%
5Strong Sell3.06%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth B Momentum A VGM

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 15% (217 out of 254)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Trades from $1

Company Summary

Quidel Corp. discovers, develops, manufactures and markets point-of-care, rapid diagnostic tests for detection of medical conditions and illnesses. These products provide accurate, rapid and cost-effective diagnostic information for acute and chronic conditions that affect women's health throughout the phases of their lives including reproductive status, pregnancy management and osteoporosis. Quidel also provides point-of-care diagnostics for infectious diseases, including influenza A and B, strep throat, H. pylori infection, chlamydia and infectious mononucleosis.

General Information

Quidel Corporation



Phone: 858-552-1100

Fax: 858-453-4338



Industry Medical - Products
Sector Medical
Fiscal Year End December
Last Reported Quarter 3/31/2021
Next EPS Date 5/5/2021

EPS Information

Current Quarter EPS Consensus Estimate 5.26
Current Year EPS Consensus Estimate 28.15
Estimated Long-Term EPS Growth Rate 25.00
Next EPS Report Date 5/5/2021

Price and Volume Information

Zacks Rank Premium
Yesterday's Close 122.32
52 Week High 306.72
52 Week Low 106.13
Beta 0.08
20 Day Moving Average 691,281.38
Target Price Consensus 226.50


% Price Change
4 Week -12.55
12 Week -48.71
YTD -33.48
% Price Change Relative to S&P 500
4 Week -17.23
12 Week -52.50
YTD -39.57
Share Information
Shares Outstanding (millions) 42.54
Market Capitalization (millions) 5,203.83
Short Ratio NA
Last Split Date NA
Dividend Information
Dividend Yield 0.00%
Annual Dividend $0.00
Payout Ratio 0.00
Change in Payout Ratio 0.00
Last Dividend Payout / Amount NA / $0.00

Fundamental Ratios

P/E (F1) 4.35
Trailing 12 Months 6.14
PEG Ratio 0.17
EPS Growth
vs. Previous Year 1,064.89%
vs. Previous Quarter 92.78%
Sales Growth
vs. Previous Year 431.75%
vs. Previous Quarter 69.98%
Price Ratios
Price/Book 3.86
Price/Cash Flow 5.67
Price / Sales 3.13
3/31/21 NA
12/31/20 100.31
9/30/20 63.31
3/31/21 NA
12/31/20 67.38
9/30/20 40.55
Current Ratio
3/31/21 NA
12/31/20 3.39
9/30/20 2.70
Quick Ratio
3/31/21 NA
12/31/20 3.05
9/30/20 2.24
Operating Margin
3/31/21 NA
12/31/20 51.30
9/30/20 41.37
Net Margin
3/31/21 NA
12/31/20 48.76
9/30/20 36.91
Pre-Tax Margin
3/31/21 NA
12/31/20 62.61
9/30/20 45.52
Book Value
3/31/21 NA
12/31/20 31.68
9/30/20 20.19
Inventory Turnover
3/31/21 NA
12/31/20 3.47
9/30/20 3.45
3/31/21 NA
12/31/20 0.00
9/30/20 0.00
Debt to Capital
3/31/21 NA
12/31/20 0.00
9/30/20 0.00